Implement best practice recommendations for ILD screening and assessment of risk for progressive ILD in patients with SSc
|
|
|
|
|
|
Outline a tailored approach to SSc-ILD treatment that is consistent with current clinical trial evidence in support of new regimens
|
|
|
|
|
|
Utilize communication strategies that facilitate accurate symptom reporting, improve disease understanding, and promote treatment adherence among patients with SSc-ILD
|
|
|
|
|
|